Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi(Aichi Cancer Center), Satoshi Morita(Yokohama City University Medical Center), Yasushi Yatabe(Aichi Cancer Center), Shunichi Negoro(Hyogo Prefectural Cancer Center), Isamu Okamoto(Kindai University), Junji Tsurutani(Kindai University), Takashi Seto(National Hospital Organization Kyushu Cancer Center), Miyako Satouchi(Hyogo Prefectural Cancer Center), Hirohito Tada(Osaka City General Hospital), Tomonori Hirashima(Osaka Prefectural Medical Center), Kazuhiro Asami(National Kinki Chuo Hospital for Chest Disease), Nobuyuki Katakami(Kobe City Medical Center General Hospital), Minoru Takada(Kindai University), Hiroshige Yoshioka(Kurashiki Central Hospital), Kazuhiko Shibata(Kouseiren Takaoka Hospital), Shinzoh Kudoh(Osaka City University), Eiji Shimizu(Tottori University), Hiroshi Saito(Aichi Cancer Center), Shinichi Toyooka(Okayama University), Kazuhiko Nakagawa(Kindai University), Masahiro Fukuoka(Kindai University)
Cited by 4,111
Abstract
Related Papers
No related papers found
Powered by citation graph analysis